Application 210663
- Type
- ANDA
- Sponsor
- BRECKENRIDGE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE | SYRUP;ORAL | 1.5MG/5ML;5MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210663-001 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | 2019-06-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A210663-001 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | 2019-06-11 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A210663-001 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | 2019-06-11 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A210663-001 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | 2019-06-11 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210663-001 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | 2019-06-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A210663-001 | AA | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | KVK-Tech, Inc. | 26d7c90c-5e6b-4bdb-b06f-c76173a01c21 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION | KVK-Tech, Inc. | 9a737416-08e0-4df6-897e-cf9d1b5f0b01 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Genus Lifesciences Inc. | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | PAI Holdings, LLC dba PAI Pharma | 71319a6f-aaf4-4bc5-8b40-a16c6f139be6 | 2026-02-28 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Novel Laboratories, Inc. | 4050ae05-7f1a-48b7-99b9-f8db8aa02741 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Lupin Pharmaceuticals,Inc. | 41ac90b3-f007-4eb2-9d41-ea626ced2017 | 2024-09-12 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Novel Laboratories, Inc. | b203c87c-1108-4eaa-8a57-87be776d8a70 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | Hydrocodone Bitartrate and Homatropine Methylbromide |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.